The breast cancer markers Estrogen Receptor alpha (ERα) and Human Epidermal Growth Factor Receptor 2 (HER2) were examined at protein level (Figure 4C), however there was no significant difference between the two cohorts. This evidence concerns the gene ESR1 and breast carcinoma.